Medtronic’s Deep Brain Stimulation (DBS) mission is to alleviate pain, restore health, and extend life by providing innovative neurostimulation technologies for Parkinson’s disease, epilepsy, and other disorders. They focus on personalized, 24/7 symptom control using BrainSense™ technology to improve patient independence. 

Core Aspects of the Mission:
Disease Management: Primarily targets movement symptoms (tremor, rigidity, bradykinesia) in Parkinson’s disease.
Innovation & Technology: Uses Percept™ DBS neurostimulators with BrainSense™ technology to capture and record brain signals for personalized, data-driven, real-time therapy.
Patient Focus: Aims to enhance quality of life, allowing for more independence and improved ability to perform daily activities.
Safety & Reliability: Features include safe, full-body MRI access and robust device design that resists interference from daily, everyday items.
Therapeutic Flexibility: Systems are adjustable, reversible, and designed for long-term management of neurological conditions. 
Related to "Medtronic DBS Recall":
Search results did not contain information regarding a specific, current recall of Medtronic DBS devices.